Hepion Pharmaceuticals, Inc. (HEPA) Ownership

$0.32

south_east
-$0.07 (-18.8%)
Day's range
$0.31
Day's range
$0.41

Hepion Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
XTX TOPCO LTD 08/12/2025 17.36 K $1.39 K   100.00% 0.61%
FMR LLC 08/14/2025 0 $0   -100.00% 0.00%
PNC FINANCIAL SERVICES GROUP, INC. 08/08/2025 0 $0   -100.00% 0.00%
MORGAN STANLEY 08/15/2025 0 $0   -100.00% 0.00%
GROUP ONE TRADING, L.P. 08/14/2025 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 08/14/2025 0 $0   -100.00% 0.00%
HRT FINANCIAL LP 08/14/2025 0 $0   -100.00% 0.00%
ANSON FUNDS MANAGEMENT LP 08/14/2025 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/15/2025 0 $0   -100.00% 0.00%
SABBY MANAGEMENT, LLC 08/14/2025 0 $0   -100.00% 0.00%
ALLWORTH FINANCIAL LP 08/07/2025 0 $0   -100.00% 0.00%
SBI SECURITIES CO., LTD. 08/08/2025 0 $0   -100.00% 0.00%
BLACKROCK, INC. 08/12/2025 0 $0   -100.00% 0.00%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 08/14/2025 0 $0   -100.00% 0.00%

Hepion Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 6 institutional investors and hedge funds held shares of Hepion Pharmaceuticals, Inc.. The most heavily invested institutionals were:

XTX Topco Ltd: 0

BlackRock Inc.: 82,954

BerganKDV Wealth Management, LLC: 1

SAN FRANCISCO SENTRY INVESTMENT GROUP (CA): 10,000

LADENBURG THALMANN FINANCIAL SERVICES INC.: 47

Advisor Group, Inc.: 1

0.61% of Hepion Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 93.00 K shares in the last 24 months. This purchase volume represents approximately $29.57 K in transactions.